In patients with Gastroesophageal Reflux Disease is Esomeprazole the most efficient proton pump inhibitor to induce mucosal healing? Introdução à Medicina.

Slides:



Advertisements
Similar presentations
Proton Pump Inhibitors
Advertisements

A 50-year-old man with a history of symptomatic gastroesophageal reflux disease (GERD) has Barrett’s esophagus diagnosed on upper endoscopy. Which of.
Application of e-Learning in Under-Graduated Medical Teaching A Systematic Review Authors: Ana Carolina Martins, Ana Rita Figueiredo, Bruno Reis, Carolina.
Nursing Care of Patients WithUpper GI Disturbances
Class st Year Introdução à Medicina I FMUP 19 th December 2007.
Topics Background Treatment Reading Assignments/Questions References
Pediatric Laproscopic Nissen Fundoplication
Journal Club: Biologic Agents in UC, Systematic Review and Network Meta-analysis, by Danese et al., Annals 2014 Barrett G. Levesque, MD Assistant Professor.
Turma 6 Bárbara Vieira, Diana Pires, Iolanda Vieira, João Novo, José Machado, Lia Rodrigues, Maria Lume, Mário Sousa, Mónica Pereira, Patrícia Gouveia,
Universidade do Porto Faculdade de Medicina Introdução à Medicina Application of e-Learning in Under-Graduated Medical Teaching A Systematic Review Authors:
GERD and Peptic ulcer disease
So You Want to Do Comparative Effectiveness Research? The Nuts and Bolts of CER.
Cellular Phone-Based Technologies For Monitoring Of Patients With Chronic Diseases Systematic Review And Meta-Analysis.
1 Literature Review Peter R. McNally, DO, FACP, FACG Lone Tree, Colorado.
The Co-existence and Severity of Acid and Alkaline Reflux in Pediatric and Adult Patients with Eosinophilic Esophagitis Asif Shah University at Buffalo.
UOG Journal Club: September 2012 Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis Sotiriadis A,
In patients with Gastroesophageal Reflux Disease is Esomeprazole the most effective proton pump inhibitor to induce mucosal healing and/or to maintain.
1 A Meta-analysis on the Sensitivity and Specificity of Exhaled Nitric Oxide and Induced Sputum Eosinophilia for the Diagnosis of Asthma Introdução à Medicina.
M EDICAL S TUDENTS A TTITUDES AND K NOWLEDGE TOWARDS B IOSTATISTICS Faculdade de Medicina da Universidade do Porto Introdução à Medicina – 2007/2008 Class.
1 Assessment of Quality Of Life in patients treated with Chemo and Radiotherapy for Gastric Cancer: A Systematic Review Authors: Turma 14 Supervisors:
EBD for Dental Staff Seminar 1: Educational prescription, structured questions and effective searching Dominic Hurst evidenced.qm.
GastroEsophageal Reflux Disease (GERD)
Gastroesophageal Reflux Disease
Agency for Healthcare Research and Quality (AHRQ)
Gastro-Esophageal Reflux Disease
GERD Jaspreet Kaur 1488 MD 4.
1 OTC Omeprazole Magnesium (Prilosec 1 TM ) October 20, 2000 Larry Goldkind MD Division of Gastrointestinal and Coagulation Drug Products CDER, FDA.
Gastroesophageal Reflux Disease: Beyond Heartburn Annette Y. Kwon, M.D. Edward W. Holt, M.D. October 1, 2011.
1 Session 3 Basic Results Database Deborah A. Zarin, M.D. Background Specific Results Data Elements Data Entry and Display Mockups.
Introdução à Medicina Faculdade de Medicina da Universidade do Porto Introdução à Medicina Home monitoring in respiratory chronic diseases: systematic.
Genetic polymorphisms of Cox enzyme and risk of colon adenoma and adenocarcinoma: A systematic review Introdução à Medicina Faculdade de Medicina da Universidade.
Quality of life after abdominal aortic aneurysm repair: endovascular repair vs open repair A Systematic Review.
Gastroesophageal Reflux Disease (GERD)
gastroesophageal reflux disease GERD
Edward Auyang, MD, MS, FACS Assistant Professor of Surgery
New Techniques and Perspectives Presented on: May 17th 2014
Gastrointestinal Pharmacology
A gastroenterologist’s view of GERD and its pre-operative workup
1 Proton-Pump Inhibitor (PPI) Template for Pediatric Written Requests Pediatric Advisory Subcommittee of the Anti- Infective Drug Advisory Committee Hugo.
 Gastro-Oesophageal Reflux Disorder ● Present in around 10% of the population ● Symptoms or damage to the mucosal lining of the distal oesophagus ● Caused.
Update of TARGET ( T reatment a nd R elief of G astroint e s t inal disorder) DR NORITA YASMIN MORNING READ 19/9/13 1.
Clinical features of Upper GI origin More than 4 weeks duration Pain induced or worsened by food 40% of adults have in a life time Generally benign – promote.
General Principles Of Treatment. Treatment Goals To relieve the symptoms of Benign (Peptic Stricture) To improve patient’s nutritional status.
Class 15, 1st year Introdução à Medicina II 28th May 2010
Gastrointestinal Diseases Dr. Maha Arafah Pathology, 2012.
1 PHOTOFRIN® PDT for High-grade Dysplasia in Barrett’s Esophagus Edvardas Kaminskas, M.D. Medical Officer, CDER, ODE III, DGCDP Milton Fan, Ph.D. Statistical.
The Role of Secondary Versus Tertiary Prevention in Decreasing the Incidence of Esophageal Adenocarcinoma in Patients with Barrett’s Esophagus Lindsay.
A SYSTEMATIC REVIEW OF THE VALIDITY OF ENDOSCOPIC ULTRASOUND FOR GASTRIC CARCINOMA STAGING Turma 15 Supervisors Prof. Doutor Altamiro da Costa Pereira.
GROUP D.  narrowing of the esophagus(distal) near the junction with the stomach (squamocolumnar jxn).  sequelae of gastroesophageal reflux– induced.
1 Clinical Overview Omeprazole Magnesium (Prilosec 1 TM ) June 21, 2002 Mark Avigan, MD CM Division of Gastrointestinal and Coagulation Drug Products CDER,
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Efficacy of Omeprazole for the Treatment of Symptomatic.
Gastroesophageal Reflux Disease (GERD). * Definition: inflammation of the lower part of the esophagus due to abnormal reflux of gastric contents into.
HELICOBACTER PYLORI Millions of years old microorganism of mankind Causes a spectrum of diseases Obviously requires high priority Treatment strategies.
The Impact of Lifestyle Modification on the Health-Related Quality of Life of Patients With Reflux Esophagitis Receiving Treatment With a Proton Pump Inhibitor.
Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors F Zerbib, A Duriez, S Roman, M.
Evaluation of effectiveness and safety of acyclovir 1gm twice a day for treatment of recurrent genital herpes Kaushal Verma, M Sunane, Somesh Gupta All.
GI For Rehabilitation.
Intervista a Angelo Delmonte
Yoshida Study Good day doctor/s!
Drugs for Peptic Ulcer Disease
Contribution by: Prof. Dr. J.J. Kolkman
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Effectiveness of proton pump inhibitors in nonerosive reflux disease
Lecture -10 Gastrointestinal Disorders Gastroesophageal Reflex Disease
Volume 156, Issue 5, Pages (April 2019)
Overview of medical therapy for gastroesophageal disease

Presentation transcript:

In patients with Gastroesophageal Reflux Disease is Esomeprazole the most efficient proton pump inhibitor to induce mucosal healing? Introdução à Medicina II Class 16

Summary Rationale GERD PPIs Esomeprazole Study question, aim Methods Results Conclusions Gastroesophageal Reflux Disease (GERD) The reflux of the stomach contents into the esophagus. symptoms complications Causes a range of troublesome symptoms: - heartburn; - acid regurgitation; - (…) and complications: - hemorrhage, stricture; - Barrett’s esophagus; - adenocarcinoma of the distal esophagus. Vakil et al Sonnenberg et al, 1999

Proton Pump Inhibitors (PPIs) Heal esophageal mucosal injury. Highly selective and effective in their action and have few short or long-term adverse effects. Eg.: Esomeprazole, Lansoprazole, Omeprazole, Pantoprazole, Rabeprazole. Pettit M (2005). Treatment of gastroesophageal reflux disease. Pharm World Sci. 27 (6): Summary Rationale GERD PPIs Esomeprazole Study question, aim Methods Results Conclusions

Esomeprazole It’s administration offers several pharmacokinetic advantages relatively to the first generation of PPIs. Coron E, Hatlebakk JG, Galmiche JP (2007). Medical therapy of gastroesophageal reflux disease. Curr Opin Gastroenterol.23(4): Several studies have shown marginal differences in efficacy between various proton pump inhibitor regimens. Glatzel D, Abdel-Qader M, Gatz G, Pfaffenberger B (2006). Pantoprazole 40 mg is as effective as Esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse. Digestion. 74(3-4): Summary Rationale GERD PPIs Esomeprazole Study question, aim Methods Results Conclusions

Study question Is Esomeprazole more effective in healing mucosal injury, relatively to Omeprazole, Lansoprazole, Rabeprazole, Pantoprazole, in GERD patients? Aim To compare efficacy of Esomeprazole relatively to others PPIs in:  inducing mucosal healing in GERD patients. Summary Rationale Study question, aim Methods Results Conclusions

Study design  Systematic review. Bibliographic databases Medline ( Scopus ( ISI Web of Knowledge ( Inclusion and exclusion criteria Inclusion criteria:  randomized clinical trials;  focused on human adults (18 – 75 years old) with GERD;  treatment only with PPIs (Esomeprazole vs other);  until December of Exclusion criteria:  studies in pregnant;  studies in people with other illnesses beyond GERD. Summary Rationale Study question, aim Methods Study design Bibliographic databases Inclusion and exclusion criteria Data to be extracted Results Conclusions Methods

Methods Data to be extracted: - number of individuals included in the study; - number of participants that abandoned the study; - reasons of abandonment; - number of treated individuals; - number of treated men; - number of treated women; - age of the participants; - participants’ habits (smoking, drinking…); - classification of the reflux (participants’ symptoms); - duration of the study (time until healing endoscopy); Summary Rationale Study question, aim Methods Study design Bibliographic databases Inclusion and exclusion criteria Data to be extracted Results Conclusions

Methods - interventions: - Esomeprazole:. doses;. time;. other medication; - tested PPI:. doses;. time;. other medication; Summary Rationale Study question, aim Methods Study design Bibliographic databases Inclusion and exclusion criteria Data to be extracted Results Conclusions

Results ISI PUBMED SCOPUS N=214 Found articles Summary Rationale Study question, aim Methods Results Papers selection Papers description Efficacy Conclusions

Results Summary Rationale Study question, aim Methods Results Papers selection Papers description Efficacy Conclusions 214 articles 99 included 115 excluded 66 found 33 not found 12 included 54 excluded Age (3) Without Eso (36) Eso Vs placebo (5) With Eso, without comparison (3) PPI in general (3) Metanalysis (2) Evaluates quality of life (1) Evaluation of scales (1) Age (3) Without Eso (36) Eso Vs placebo (5) With Eso, without comparison (3) PPI in general (3) Metanalysis (2) Evaluates quality of life (1) Evaluation of scales (1)

 Included articles Results Summary Rationale Study question, aim Methods Results Papers selection Papers description Efficacy Conclusions * in these studies, the maximum value was not fixed. ** in this study, the mean of the ages of the participants was the variable considered

Results Summary Rationale Study question, aim Methods Results Articles Paper selection: Included articles, extracted data Efficacy Conclusions  Efficacy: Esomeprazole 20mg vs. old PPIs

Results Summary Rationale Study question, aim Methods Results Articles Paper selection: Included articles, extracted data Efficacy Conclusions  Efficacy: Esomeprazole 40mg vs. old PPIs

Conclusion With this study we found that, in general, Esomeprazole seems to be better at  healing and prevention of mucosal injury than other PPIs that already exist. Summary Rationale Study question, aims Methods Results Conclusion

Advisor: Mário Dinis Ribeiro April 18 th 2008 Ana Lopes Andreia Pinto Catarina Melo Diogo Dias Isabel Saavedra João Matias Mariana Ferreira Mariana Mangas Paula Neves Rita Sapage Rui Coelho Teresa Caridade Teresa Tavares Class 16 1 st Year Introdução à Medicina II Faculdade de Medicina da Universidade do Porto